We are live on ! Find out more
MPA

Marvin & Palmer Associates Portfolio holdings

AUM $159M
1-Year Est. Return 109.02%
This Fund
S&P 500
This Quarter Est. Return
-6.87%
1 Year Est. Return
+109.02%
3 Year Est. Return
+392.2%
5 Year Est. Return
+719.89%
10 Year Est. Return
+4,985%
AUM
$194M
AUM Growth
-$27.6M
Cap. Flow
-$9.43M
Cap. Flow %
-4.85%
Top 10 Hldgs %
50.04%
Holding
35
New
6
Increased
Reduced
10
Closed
8

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$9.52M
2
MRK icon
Merck
MRK
+$9.39M
3
LIN icon
Linde
LIN
+$9.29M
4
BMY icon
Bristol-Myers Squibb
BMY
+$8.04M
5
KLAC icon
KLA
KLAC
+$7.86M

Sector Composition

Rank Sector Weight
1 Healthcare 30.75%
2 Financials 16.71%
3 Technology 15.69%
4 Energy 13.06%
5 Industrials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
26
Applied Materials
AMAT
$428B
$735K 0.38%
8,079
GLD icon
27
SPDR Gold Trust
GLD
$141B
$559K 0.29%
3,320
-3,680
-53% -$643K
AMP icon
28
Ameriprise Financial
AMP
$48.8B
-39,140
Closed -$11.8M
GOOGL icon
29
Alphabet (Google) Class A
GOOGL
$4.33T
-42,960
Closed -$5.97M
MOO icon
30
VanEck Agribusiness ETF
MOO
$969M
-100,655
Closed -$10.5M
SCHW
31
Charles Schwab
SCHW
$187B
-92,561
Closed -$7.8M
THD icon
32
iShares MSCI Thailand ETF
THD
$372M
-24,775
Closed -$1.93M
TSCO icon
33
Tractor Supply
TSCO
$18B
-170,615
Closed -$7.96M
USRT icon
34
iShares Core US REIT ETF
USRT
$4.63B
-117,767
Closed -$7.61M
VNM icon
35
VanEck Vietnam ETF
VNM
$504M
-59,013
Closed -$1.11M

Similar funds

Marvin & Palmer Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Marvin & Palmer Associates held 35 positions worth $194M, down 12% from $222M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Marvin & Palmer Associates withdrew a net $9.43M in Q2 2022, closing 8 positions and reducing 10 holdings. Its most notable exit was Ameriprise Financial, an estimated $11.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marvin & Palmer Associates opened a new position in Eli Lilly worth $10.3M.

  • Marvin & Palmer Associates's largest Q2 2022 buy was Eli Lilly: 31,700 shares worth $10.3M.
  • Marvin & Palmer Associates's biggest Q2 2022 reduction was Fortinet, cutting an estimated $1.95M.
  • Marvin & Palmer Associates fully exited Ameriprise Financial in Q2 2022, selling an estimated $11.8M.
  • Marvin & Palmer Associates's ten largest holdings make up 50% of its $194M portfolio in Q2 2022.
  • Marvin & Palmer Associates opened 6 new positions and closed 8 in Q2 2022.
  • Marvin & Palmer Associates's portfolio value fell 12% quarter-over-quarter to $194M.

Based on Marvin & Palmer Associates's 13F filing for Q2 2022, filed 9 Aug 2022.